Thymic immune-regulating peptides (Thymalin peptide complex; Thymulin zinc-dependent nonapeptide)
These thymus-derived peptides are studied for restoring and balancing immune function, especially in aging or after illness.
| Class / type | Thymic immune-regulating peptides (Thymalin peptide complex; Thymulin zinc-dependent nonapeptide) |
|---|---|
| Category | Healing, Recovery & Immune |
| Status (Jul 2026) | Research use only |
They act on the thymus/immune axis to support T-cell differentiation and maturation and to normalize immune and inflammatory signaling; Thymulin's activity specifically depends on zinc as a cofactor.
Used in Russia and Eastern Europe (Thymalin approved there since the early 1990s) for immune deficiency, post-illness recovery, and age-related decline; studied for immune modulation including a report in severe COVID-19.
Decades of clinical use abroad, reported immune-restoring and anti-inflammatory effects, and possible benefit in immune senescence and recovery.
Not FDA-approved and little rigorous Western trial data; most evidence is older or from limited studies. Injectable use of unregulated research-grade product carries contamination and dosing risks.
Longevity and immune-support enthusiasts report subjective improvements in resilience and recovery, but firsthand accounts are limited.
NOT FDA-approved in the United States. They are research-use-only in the US, though Thymalin is approved and used clinically in Russia and some Eastern European countries.